Search Within

Martin Fleisher

Formats
  1. Journal Article (161)
  2. Meeting Abstract (140)
  3. Book Section (6)
  4. Conference Paper (4)
  5. Book Whole (1)
Groups
  1. Department of Medicine (180)
  2. Solid Tumor Oncology Division (113)
  3. Genitourinary Oncology Service (81)
  4. Epidemiology and Biostatistics (77)
  5. Hematologic Malignancies, Division of (67)
  6. Biostatistics Service (64)

More Groups

People
  1. Howard Scher (78)
  2. Daniel Danila (48)
  3. Raymond Comenzo (36)
  4. Aseem Anand (34)
  5. Glenn Heller (32)
  6. Ping Zhou (30)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Clinical Chemistry (32)
  3. Blood (26)
  4. Clinical Cancer Research (10)
  5. Cancer Research (9)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (60)
  2. American Association for Clinical Chemistry (32)
  3. American Association for Cancer Research (26)
  4. American Society of Hematology (26)
  5. Oxford University Press (19)
  6. Elsevier Inc. (16)

More Publishers

Results (312)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early detection and prognosis of ovarian cancer using serum YKL-40
    Journal Article

    Dupont, J.; Tanwar, M. K.; Thaler, H. T.; Fleisher, M.; Kauff, N.; Hensley, M. L.; Sabbatini, P.; Anderson, S.; Aghajanian, C.; Holland, E. C.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Occult blood
    Book Section

    Fleisher, M.; Schoengold, R. J.
    In Nichols, J. H. (Eds.) Point-of-Care Testing: Performance Improvement and Evidence-Based Outcomes (2003)

    Fulltext@MSK | Save
  • Tumor markers and clinical information: Do we need both?
    Meeting Abstract

    Schwartz, M. K.; Fleisher, M.; Dnistrian, A.
    Tumor Biology (2003)

    Fulltext@MSK | Save
  • A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma
    Meeting Abstract

    Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Systemic AL amyloidosis due to non-Hodgkin's lymphoma: An unusual clinicopathologic association
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Xiao, Q. X.; Fleisher, M.; Kalakonda, N.; Akhurst, T.; Chitale, D. A.; Moskowitz, C.; Dhodapkar, M. V.; Teruya-Feldstein, J.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Laboratory procedures in the diagnosis and monitoring of multiple myeloma
    Journal Article

    Fleisher, M.
    Journal of Clinical Ligand Assay (2003)

    Fulltext@MSK | Save
  • Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma
    Journal Article

    Wolchok, J. D.; Williams, L.; Pinto, J. T.; Fleisher, M.; Krown, S. E.; Hwu, W. J.; Livingston, P. O.; Chang, C.; Chapman, P. B.
    Melanoma Research (2003)

    Fulltext@MSK | Save
  • Criteria for tumor marker evaluation and utilization
    Journal Article

    Fleisher, M.
    MLO: Medical Laboratory Observer (2003)

    Fulltext@MSK | Save
  • Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations
    Journal Article

    Eastham, J. A.; Riedel, E.; Scardino, P. T.; Shike, M.; Fleisher, M.; Schatzkin, A.; Lanza, E.; Latkany, L.; Begg, C. B.
    JAMA - Journal of the American Medical Association (2003)

    Fulltext@MSK | Save